Analysts: Uroplasty Inc (UPI.OQ)
UPI.OQ on NASDAQ Stock Exchange Capital Market
2.28USD
1 Aug 2013
2.28USD
1 Aug 2013
Price Change (% chg)
$0.01 (+0.44%)
$0.01 (+0.44%)
Prev Close
$2.27
$2.27
Open
$2.25
$2.25
Day's High
$2.29
$2.29
Day's Low
$2.24
$2.24
Volume
600
600
Avg. Vol
19,949
19,949
52-wk High
$4.32
$4.32
52-wk Low
$1.69
$1.69
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -0.04 | March | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 0 | 0 | 0 | 0 |
| (2) OUTPERFORM | 3 | 3 | 3 | 2 |
| (3) HOLD | 2 | 2 | 3 | 4 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.40 | 2.40 | 2.50 | 2.67 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 3 | 6.04 | 6.11 | 5.90 | 6.76 |
| Quarter Ending Dec-13 | 3 | 6.28 | 6.30 | 6.22 | 7.10 |
| Year Ending Mar-13 | 6 | 22.55 | 22.90 | 22.40 | -- |
| Year Ending Mar-14 | 4 | 25.06 | 28.50 | 22.80 | 27.96 |
| Year Ending Mar-15 | 2 | 27.20 | 29.80 | 24.60 | -- |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 4 | -0.04 | -0.03 | -0.04 | -0.02 |
| Quarter Ending Dec-13 | 4 | -0.03 | -0.02 | -0.04 | -0.01 |
| Year Ending Mar-13 | 6 | -0.16 | -0.13 | -0.19 | -- |
| Year Ending Mar-14 | 4 | -0.14 | -0.13 | -0.16 | -0.06 |
| Year Ending Mar-15 | 2 | -0.05 | -0.01 | -0.08 | -- |
| LT Growth Rate (%) | 1 | 25.00 | 25.00 | 25.00 | 22.50 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 5.59 | 5.54 | 0.05 | 0.87 |
| Quarter Ending Dec-12 | 6.10 | 5.59 | 0.51 | 8.43 |
| Quarter Ending Sep-12 | 5.64 | 5.71 | 0.07 | 1.21 |
| Quarter Ending Jun-12 | 5.82 | 5.58 | 0.24 | 4.16 |
| Quarter Ending Mar-12 | 5.51 | 5.60 | 0.09 | 1.58 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | -0.04 | -0.05 | 0.01 | -25.00 |
| Quarter Ending Dec-12 | -0.04 | -0.03 | 0.01 | -18.26 |
| Quarter Ending Sep-12 | -0.05 | -0.03 | 0.02 | -35.76 |
| Quarter Ending Jun-12 | -0.04 | -0.04 | 0.00 | -5.26 |
| Quarter Ending Mar-12 | -0.07 | -0.01 | 0.06 | -84.85 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 6.04 | 6.04 | 6.04 | 6.02 | 6.76 |
| Quarter Ending Dec-13 | 6.28 | 6.28 | 6.29 | 6.16 | 7.10 |
| Year Ending Mar-13 | 22.55 | -- | -- | -- | -- |
| Year Ending Mar-14 | 25.06 | 25.06 | 24.14 | 24.07 | 27.96 |
| Year Ending Mar-15 | 27.20 | 27.20 | 27.20 | 27.20 | -- |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | -0.04 | -0.04 | -0.04 | -0.04 | -0.02 |
| Quarter Ending Dec-13 | -0.03 | -0.03 | -0.03 | -0.03 | -0.01 |
| Quarter Ending Mar-13 | -0.16 | -- | -- | -- | -- |
| Quarter Ending Mar-14 | -0.14 | -0.14 | -0.14 | -0.13 | -0.06 |
| Quarter Ending Mar-15 | -0.05 | -0.05 | -0.05 | -0.05 | -- |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 1 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 1 |
| Year Ending Mar-13 | -- | -- | -- | -- |
| Year Ending Mar-14 | 0 | 0 | 2 | 0 |
| Year Ending Mar-15 | 0 | 0 | 0 | 0 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Mar-13 | -- | -- | -- | -- |
| Year Ending Mar-14 | 0 | 0 | 0 | 0 |
| Year Ending Mar-15 | 0 | 0 | 0 | 0 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates